Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai
Patent
1993-10-27
1997-01-07
Shah, Mukund J
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Cyclopentanohydrophenanthrene ring system doai
540 96, 540 97, C07J 4300, A61K 3158
Patent
active
055917356
ABSTRACT:
There is disclosed novel, therapeutically active androstane derivatives having neuromuscular blocking effect, which are substituted by a quaternary ammonium group in 16-position; pharmaceutically composition containing them; process for producing them; and novel intermediates for the production.
REFERENCES:
patent: 4177190 (1979-12-01), Tuba et al.
Buckett et al, Jour. of Med. Chemistry vol. 16 pp. 1116-1124 (1973).
Zoltan Tuba et al., "Structure-Activity Relationships of Steroidal Neuromuscular Blocking Agents", Molecular Structure and Bioilogical Activity of Steroids, Chapter 11, pp. 359-397 (Aug. 1992).
Foldes Francis F.
Maho Sandor
Tuba Zoltan
Vizi E. Szilveszter
Bottino Anthony
Marvishi Pharmaceutical Co., Ltd.
Shah Mukund J
LandOfFree
Androstane derivatives substituted by a quaternary ammonium grou does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Androstane derivatives substituted by a quaternary ammonium grou, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Androstane derivatives substituted by a quaternary ammonium grou will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1764295